{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T13:02:07Z","timestamp":1770469327265,"version":"3.49.0"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Dengue is caused by the four serotypes of dengue virus (DENV-1-4) and poses a significant global public health challenge, with an estimated 100\u2013400 million infections annually. Severe dengue manifestations, such as Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS), are influenced by immune responses, particularly during secondary infections with different serotypes. Antibody-dependent enhancement (ADE) of DENV infection is a critical mechanism in dengue immunopathogenesis, underscoring the need for comprehensive evaluation of antibody responses. Traditional cell lines used for DENV propagation exhibit variability and present logistical challenges for assessing non-neutralizing antibody functions. Here, we report the establishment of a stable CEM-NK<jats:sup>R<\/jats:sup> cell line expressing DC-SIGN, designated CEM2001, capable of supporting continuous infection with all four DENV serotypes. These cell lines allow for continuous DENV infection, enabling detailed immunoassays to evaluate serotype-specific and cross-reactive non-neutralizing antibody responses. Our approach offers a significant advancement in dengue research, providing a consistent and reliable system to study DENV immune responses and supporting future efforts to develop and evaluate dengue therapeutics and vaccines.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1618650","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T05:22:32Z","timestamp":1750742552000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Applications and insights from continuous dengue virus infection in a stable cell line"],"prefix":"10.3389","volume":"16","author":[{"given":"M. Jane","family":"Morwitzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying Yi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Friberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey R.","family":"Currier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/v2122649","article-title":"The complexity of antibody-dependent enhancement of dengue virus infection","volume":"2","author":"Guzman","year":"2010","journal-title":"Viruses"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60572-9","article-title":"Dengue","volume":"385","author":"Guzman","year":"2015","journal-title":"Lancet"},{"key":"B4","unstructured":"Improving data for dengue"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-019-0476-8","article-title":"The current and future global distribution and population at risk of dengue","volume":"4","author":"Messina","year":"2019","journal-title":"Nat Microbiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a113932","article-title":"Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak","volume":"120","author":"Sangkawibha","year":"1984","journal-title":"Am J Epidemiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1997.56.566","article-title":"Risk factors in dengue shock syndrome","volume":"56","author":"Thein","year":"1997","journal-title":"Am J Trop Med Hyg"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.13-0424","article-title":"Characteristics of mild dengue virus infection in Thai children","volume":"89","author":"Yoon","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nri3014","article-title":"Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms","volume":"11","author":"Rothman","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-013-1645-3","article-title":"Secondary infection as a risk factor for dengue hemorrhagic fever\/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection","volume":"158","author":"Guzman","year":"2013","journal-title":"Arch Virol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1086\/jid.2004.189.issue-2","article-title":"Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles","volume":"189","author":"Nguyen","year":"2004","journal-title":"J Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00220-10","article-title":"Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection","volume":"85","author":"Boonnak","year":"2011","journal-title":"J Virology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.580096","article-title":"Intrinsic ADE: the dark side of antibody dependent enhancement during dengue infection","volume":"10","author":"Narayan","year":"2020","journal-title":"Front Cell Infection Microbiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"100712","DOI":"10.1016\/j.eclinm.2020.100712","article-title":"Global, regional, and national dengue burden from 1990 to 2017: A systematic analysis based on the global burden of disease study 2017","volume":"32","author":"Zeng","year":"2021","journal-title":"EClinicalMedicine"},{"key":"B15","article-title":"DENGVAXIA","year":""},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(23)00522-3","article-title":"Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4\u00b75-year results from a phase 3, randomised, double-blind, placebo-controlled trial","volume":"12","author":"Tricou","year":"2024","journal-title":"Lancet Glob Health"},{"key":"B17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri.2017.106","article-title":"Beyond binding: antibody effector functions in infectious diseases","volume":"18","author":"Lu","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require Fc\u03b3R interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection","volume":"126","author":"DiLillo","year":"2016","journal-title":"J Clin Invest"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4873","DOI":"10.1016\/j.cell.2022.11.012","article-title":"Antibody effector functions are associated with protection from respiratory syncytial virus","volume":"185","author":"Bartsch","year":"2022","journal-title":"Cell"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2022.12.010","article-title":"Antibodies face the challenge against human respiratory syncytial virus","volume":"31","author":"de Vries","year":"2023","journal-title":"Cell Host Microbe"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00281-21","article-title":"COVID-19 severity is associated with differential antibody fc-mediated innate immune functions","volume":"12","author":"Adeniji","year":"2021","journal-title":"mBio"},{"key":"B23","doi-asserted-by":"publisher","first-page":"100510","DOI":"10.1016\/j.xcrm.2022.100510","article-title":"SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivity","volume":"3","author":"Richardson","year":"2022","journal-title":"Cell Rep Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01068-z","article-title":"Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations","volume":"22","author":"Dussupt","year":"2021","journal-title":"Nat Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abm3151","article-title":"Antibody Fc characteristics and effector functions correlate with protection from symptomatic dengue virus type 3 infection","volume":"14","author":"Dias","year":"2022","journal-title":"Sci Transl Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"New Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"New Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac476","article-title":"Antibodies produced in response to a live-attenuated dengue vaccine are functional in activating the complement system","volume":"227","author":"Nascimento","year":"2023","journal-title":"J Infect Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jviromet.2014.08.023","article-title":"Isolation and propagation of Dengue virus in Vero and BHK-21 cells expressing human DC-SIGN stably","volume":"209","author":"Phanthanawiboon","year":"2014","journal-title":"J Virol Methods"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.2001.tb02627.x","article-title":"Comparative sequences of two type 1 dengue virus strains possessing different growth characteristics in vitro","volume":"45","author":"Ishak","year":"2001","journal-title":"Microbiol Immunol"},{"key":"B32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102733","article-title":"Transcriptional and clonal characterization of B cell plasmablast diversity following primary and secondary natural DENV infection","volume":"54","author":"Waickman","year":"2020","journal-title":"eBioMedicine"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006934","article-title":"Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes","volume":"14","author":"Gallichotte","year":"2018","journal-title":"PloS Pathogens"},{"key":"B34","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41467-023-44330-8","article-title":"Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype","volume":"15","author":"Bos","year":"2024","journal-title":"Nat Commun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2018.12.003","article-title":"Isolation and molecular characterization of dengue virus clinical isolates from pediatric patients in New Delhi","volume":"84","author":"Kar","year":"2019","journal-title":"Int J Infect Diseases"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s43856-023-00378-7","article-title":"Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection","volume":"3","author":"Anantharaj","year":"2023","journal-title":"Commun Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"18404","DOI":"10.1038\/s41598-020-75042-4","article-title":"Experimental adaptation of dengue virus 1 to Aedes albopictus mosquitoes by in vivo selection","volume":"10","author":"Bellone","year":"2020","journal-title":"Sci Rep"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s41467-021-21384-0","article-title":"A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans","volume":"12","author":"Nivarthi","year":"2021","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.virol.2016.06.022","article-title":"Enhancing dengue virus maturation using a stable furin over-expressing cell line","volume":"497","author":"Mukherjee","year":"2016","journal-title":"Virology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.molcel.2019.11.007","article-title":"Altered m6A modification of specific cellular transcripts affects flaviviridae infection","volume":"77","author":"Gokhale","year":"2020","journal-title":"Mol Cell"},{"key":"B41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jviromet.2007.01.008","article-title":"Characterization of dengue virus NS1 stably expressed in 293T cell lines","volume":"142","author":"Noisakran","year":"2007","journal-title":"J Virol Methods"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad122","article-title":"Soluble NS1 antagonizes IgG- and IgA- mediated monocytic phagocytosis of DENV infected cells","volume":"228","author":"Waldran","year":"2023","journal-title":"J Infect Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.710300","article-title":"Longitudinal analysis of dengue virus\u2013specific memory T cell responses and their association with clinical outcome in subsequent DENV infection","volume":"12","author":"Sanchez-Vargas","year":"2021","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae137","article-title":"Protective role of NS1-specific antibodies in the immune response to dengue virus through antibody-dependent cellular cytotoxicity","volume":"230","author":"Sanchez-Vargas","year":"2024","journal-title":"J Infect Dis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"ofae720","DOI":"10.1093\/ofid\/ofae720","article-title":"Dengue virus structural proteins are expressed on the surface of DENV-infected cells and are a target for antibody-dependent cellular phagocytosis","volume":"12","author":"Waldran","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/BF01310705","article-title":"Dengue-2 virus infection of human mononuclear cell lines and establishment of persistent infections","volume":"110","author":"Kurane","year":"1990","journal-title":"Arch Virol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00116-07","article-title":"Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation","volume":"81","author":"Mondotte","year":"2007","journal-title":"J Virol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.2144\/btn-2018-0065","article-title":"Overlooked benefits of using polyclonal antibodies","volume":"65","author":"Ascoli","year":"2018","journal-title":"BioTechniques"},{"key":"B49","unstructured":"The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice\n          \n          \n            \n              Schlesinger\n              JJ\n            \n            \n              Foltzer\n              M\n            \n            \n              Chapman\n              S\n            \n          \n          \n          1993"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.80.3.1340-1351.2006","article-title":"Antibodies against West Nile Virus Nonstructural Protein NS1 Prevent Lethal Infection through Fc \u03b3 Receptor-Dependent and -Independent Mechanisms","volume":"80","author":"Chung","year":"2006","journal-title":"J Virol."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.05859-11","article-title":"Poorly Neutralizing Cross-Reactive Antibodies against the Fusion Loop of West Nile Virus Envelope Protein Protect In Vivo via Fc\u03b3 Receptor and Complement-Dependent Effector Mechanisms","volume":"85","author":"Vogt","year":"2011","journal-title":"J Virol."},{"key":"B52","unstructured":"Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancy\n          \n          \n            \n              Wessel\n              AW\n            \n            \n              Kose\n              N\n            \n            \n              Bombardi\n              RG\n            \n            \n              Roy\n              V\n            \n            \n              Chantima\n              W\n            \n            \n              Mongkolsapaya\n              J\n            \n          \n          \n          2020"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv289","article-title":"Human CD8+ T-cell responses against the 4 dengue virus serotypes are associated with distinct patterns of protein targets","volume":"212","author":"Weiskopf","year":"2015","journal-title":"J Infect Dis"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02129-14","article-title":"The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes","volume":"89","author":"Weiskopf","year":"2015","journal-title":"J Virol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.10.006","article-title":"Protective role of cross-reactive CD8 T cells against dengue virus infection","volume":"13","author":"Elong Ngono","year":"2016","journal-title":"EBioMedicine"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02147-16","article-title":"Human CD4+ T cell responses to an attenuated tetravalent dengue vaccine parallel those induced by natural infection in magnitude, HLA restriction, and antigen specificity","volume":"91","author":"Angelo","year":"2017","journal-title":"J Virol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41541-024-00967-0","article-title":"Long term T cell response and safety of a tetravalent dengue vaccine in healthy children","volume":"9","author":"Mandaric","year":"2024","journal-title":"NPJ Vaccines"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.179771","article-title":"Frequency of dengue virus-specific T cells is related to infection outcome in endemic settings","volume":"10","author":"G\u00e1lvez","year":"2025","journal-title":"JCI Insight"},{"key":"B59","doi-asserted-by":"publisher","first-page":"115366","DOI":"10.1016\/j.celrep.2025.115366","article-title":"Distinct features of a peripheral T helper subset that drives the B cell response in dengue virus infection","volume":"44","author":"Ansari","year":"2025","journal-title":"Cell Rep"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41541-023-00658-2","article-title":"Is new dengue vaccine efficacy data a relief or cause for concern","volume":"8","author":"Thomas","year":"2023","journal-title":"NPJ Vaccines"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80694-7","article-title":"DC-SIGN, a dendritic cell\u2013specific HIV-1-binding protein that enhances trans-infection of T cells","volume":"100","author":"Geijtenbeek","year":"2000","journal-title":"Cell"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.10.4664-4672.2001","article-title":"DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus","volume":"75","author":"P\u00f6hlmann","year":"2001","journal-title":"J Virol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2002.1730","article-title":"DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells","volume":"305","author":"Simmons","year":"2003","journal-title":"Virology"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.21.12090-12095.2004","article-title":"DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus","volume":"78","author":"Marzi","year":"2004","journal-title":"J Virol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.11.5642-5650.2004","article-title":"pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN","volume":"78","author":"Yang","year":"2004","journal-title":"J Virol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.22.12022-12032.2003","article-title":"DC-SIGN and L-SIGN can act as attachment receptors for alphaviruses and distinguish between mosquito cell- and mammalian cell-derived viruses","volume":"77","author":"Klimstra","year":"2003","journal-title":"J Virol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00354-15","article-title":"Biology of zika virus infection in human skin cells","volume":"89","author":"Hamel","year":"2015","journal-title":"J Virol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0703498104","article-title":"Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention","volume":"104","author":"oncalvez","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B69","doi-asserted-by":"publisher","first-page":"22303","DOI":"10.1038\/srep22303","article-title":"Antibody-dependent enhancement of dengue virus infection inhibits RLR-mediated Type-I IFN-independent signalling through upregulation of cellular autophagy","volume":"6","author":"Huang","year":"2016","journal-title":"Sci Rep"},{"key":"B70","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1099\/vir.0.015420-0","article-title":"Antibody-dependent enhancement of dengue virus infection in U937 cells requires cholesterol-rich membrane microdomains","volume":"91","author":"Puerta-Guardo","year":"2010","journal-title":"J Gen Virology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1618650\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T05:22:35Z","timestamp":1750742555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1618650\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":70,"alternative-id":["10.3389\/fimmu.2025.1618650"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1618650","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"article-number":"1618650"}}